Surrogate Prognostic Biomarkers in OSCC: The Paradigm of PA28γ Overexpression.
作者信息
Kontos Christos K
机构信息
Department of Biochemistry and Molecular Biology, University of Athens, Athens, Greece.
出版信息
EBioMedicine. 2015 Jul 26;2(8):784-5. doi: 10.1016/j.ebiom.2015.07.032. eCollection 2015 Aug.
Abstract
摘要
相似文献
1
Surrogate Prognostic Biomarkers in OSCC: The Paradigm of PA28γ Overexpression.口腔鳞状细胞癌中的替代预后生物标志物：PA28γ过表达的范例
EBioMedicine. 2015 Jul 26;2(8):784-5. doi: 10.1016/j.ebiom.2015.07.032. eCollection 2015 Aug.
2
Associations between proteasomal activator PA28γ and outcome of oral squamous cell carcinoma: Evidence from cohort studies and functional analyses.蛋白酶体激活剂 PA28γ 与口腔鳞状细胞癌预后的相关性：来自队列研究和功能分析的证据。
EBioMedicine. 2015 Jul 10;2(8):851-8. doi: 10.1016/j.ebiom.2015.07.004. eCollection 2015 Aug.
3
Downexpression of Matriptase-2 Correlates With Tumor Progression and Clinical Prognosis in Oral Squamous-Cell Carcinoma.基质金属蛋白酶-2的低表达与口腔鳞状细胞癌的肿瘤进展及临床预后相关。
Appl Immunohistochem Mol Morphol. 2017 Aug;25(7):481-488. doi: 10.1097/PAI.0000000000000324.
4
Co-Expression of TWIST1 and ZEB2 in Oral Squamous Cell Carcinoma Is Associated with Poor Survival.TWIST1和ZEB2在口腔鳞状细胞癌中的共表达与不良预后相关。
PLoS One. 2015 Jul 27;10(7):e0134045. doi: 10.1371/journal.pone.0134045. eCollection 2015.
5
EMMPRIN expression in oral squamous cell carcinomas: correlation with tumor proliferation and patient survival.口腔鳞状细胞癌中EMMPRIN的表达：与肿瘤增殖及患者生存率的相关性
Biomed Res Int. 2014;2014:905680. doi: 10.1155/2014/905680. Epub 2014 May 21.
6
[Construction of an oral squamous cell carcinoma cell line for stable PA28γ overexpression].[构建用于稳定过表达PA28γ的口腔鳞状细胞癌细胞系]
Hua Xi Kou Qiang Yi Xue Za Zhi. 2020 Feb 1;38(1):6-10. doi: 10.7518/hxkq.2020.01.002.
7
PA28γ acts as a dual regulator of IL-6 and CCL2 and contributes to tumor angiogenesis in oral squamous cell carcinoma.PA28γ 作为白细胞介素 6（IL-6）和趋化因子配体 2（CCL2）的双重调节剂，促进口腔鳞状细胞癌的血管生成。
Cancer Lett. 2018 Aug 1;428:192-200. doi: 10.1016/j.canlet.2018.04.024. Epub 2018 Apr 24.
8
Caspase expression in oral squamous cell carcinoma.口腔鳞状细胞癌中的半胱氨酸天冬氨酸蛋白酶表达。
Head Neck. 2011 Aug;33(8):1191-8. doi: 10.1002/hed.21602. Epub 2010 Nov 12.
9
Increased Cdc7 expression is a marker of oral squamous cell carcinoma and overexpression of Cdc7 contributes to the resistance to DNA-damaging agents.Cdc7 表达增加是口腔鳞状细胞癌的一个标志物，Cdc7 的过表达导致对 DNA 损伤剂的耐药性。
Cancer Lett. 2013 Sep 1;337(2):218-25. doi: 10.1016/j.canlet.2013.05.008. Epub 2013 May 16.
10
Tissue and serum expression of TGM-3 may be prognostic marker in patients of oral squamous cell carcinoma undergoing chemo-radiotherapy.TGM-3 在组织和血清中的表达可能是接受放化疗的口腔鳞状细胞癌患者的预后标志物。
PLoS One. 2018 Jun 28;13(6):e0199665. doi: 10.1371/journal.pone.0199665. eCollection 2018.
引用本文的文献
1
Comprehensive analysis of PSME3: from pan-cancer analysis to experimental validation.PSME3的综合分析：从泛癌分析到实验验证
Front Immunol. 2024 Jan 19;15:1295693. doi: 10.3389/fimmu.2024.1295693. eCollection 2024.
2
KRT84 is a potential tumor suppressor and good prognosis signature of oral squamous cell carcinoma.KRT84 是口腔鳞状细胞癌的潜在肿瘤抑制因子和良好预后标志物。
Biosci Rep. 2020 Apr 30;40(4). doi: 10.1042/BSR20200187.
3
[Construction of an oral squamous cell carcinoma cell line for stable PA28γ overexpression].[构建用于稳定过表达PA28γ的口腔鳞状细胞癌细胞系]
Hua Xi Kou Qiang Yi Xue Za Zhi. 2020 Feb 1;38(1):6-10. doi: 10.7518/hxkq.2020.01.002.
4
Downregulated miR-585-3p promotes cell growth and proliferation in colon cancer by upregulating .下调的miR-585-3p通过上调……促进结肠癌细胞的生长和增殖。
Onco Targets Ther. 2019 Aug 14;12:6525-6534. doi: 10.2147/OTT.S203175. eCollection 2019.
5
Alternative Splicing Detection Tool-a novel PERL algorithm for sensitive detection of splicing events, based on next-generation sequencing data analysis.可变剪接检测工具——一种基于下一代测序数据分析的用于灵敏检测剪接事件的新型PERL算法。
Ann Transl Med. 2018 Jun;6(12):244. doi: 10.21037/atm.2018.06.32.
6
Quantitative analysis and study of the mRNA expression levels of apoptotic genes , and in the articular cartilage of an animal model of osteoarthritis.骨关节炎动物模型关节软骨中凋亡基因、和的mRNA表达水平的定量分析与研究。
Ann Transl Med. 2018 Jun;6(12):243. doi: 10.21037/atm.2018.05.47.
7
Non-coding RNAs: the riddle of the transcriptome and their perspectives in cancer.非编码RNA：转录组之谜及其在癌症中的前景
Ann Transl Med. 2018 Jun;6(12):241. doi: 10.21037/atm.2018.06.10.
本文引用的文献
1
Associations between proteasomal activator PA28γ and outcome of oral squamous cell carcinoma: Evidence from cohort studies and functional analyses.蛋白酶体激活剂 PA28γ 与口腔鳞状细胞癌预后的相关性：来自队列研究和功能分析的证据。
EBioMedicine. 2015 Jul 10;2(8):851-8. doi: 10.1016/j.ebiom.2015.07.004. eCollection 2015 Aug.
2
Role of miRNA in cancer diagnosis, prognosis, therapy and regulation of its expression by Epstein-Barr virus and human papillomaviruses: With special reference to oral cancer.微小RNA在癌症诊断、预后、治疗以及爱泼斯坦-巴尔病毒和人乳头瘤病毒对其表达的调控中的作用：特别提及口腔癌
Oral Oncol. 2015 Aug;51(8):731-7. doi: 10.1016/j.oraloncology.2015.05.008. Epub 2015 Jun 17.
3
Potential biomarkers for oral squamous cell carcinoma: proteomics discovery and clinical validation.口腔鳞状细胞癌的潜在生物标志物：蛋白质组学发现与临床验证
Proteomics Clin Appl. 2015 Feb;9(1-2):86-97. doi: 10.1002/prca.201400091. Epub 2014 Dec 28.
4
A review of research on salivary biomarkers for oral cancer detection.口腔癌唾液生物标志物检测研究述评。
Clin Transl Med. 2014 Feb 24;3(1):3. doi: 10.1186/2001-1326-3-3.
5
Global cancer transitions according to the Human Development Index (2008-2030): a population-based study.全球癌症发病趋势与人类发展指数（2008-2030 年）：基于人群的研究。
Lancet Oncol. 2012 Aug;13(8):790-801. doi: 10.1016/S1470-2045(12)70211-5. Epub 2012 Jun 1.
6
Advances and applications of oral cancer basic research.口腔癌基础研究的进展与应用。
Oral Oncol. 2011 Sep;47(9):783-91. doi: 10.1016/j.oraloncology.2011.07.004. Epub 2011 Jul 29.
7
Head and neck cancer.头颈癌
Lancet. 2008 May 17;371(9625):1695-709. doi: 10.1016/S0140-6736(08)60728-X.
8
Proteasome activator PA28 gamma regulates p53 by enhancing its MDM2-mediated degradation.蛋白酶体激活剂PA28γ通过增强p53的MDM2介导的降解来调节p53。
EMBO J. 2008 Mar 19;27(6):852-64. doi: 10.1038/emboj.2008.25. Epub 2008 Feb 28.
9
Head and neck cancer: past, present and future.头颈癌：过去、现在与未来。
Expert Rev Anticancer Ther. 2006 Jul;6(7):1111-8. doi: 10.1586/14737140.6.7.1111.
10
Mobilizing the proteolytic machine: cell biological roles of proteasome activators and inhibitors.激活蛋白水解机器：蛋白酶体激活剂和抑制剂的细胞生物学作用
Trends Cell Biol. 2005 Jan;15(1):27-33. doi: 10.1016/j.tcb.2004.11.003.
Zotero 插件